Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
CN Stock MarketDetailed Quotes
688677 Qingdao Novelbeam Technology
- 32.00
- +0.57+1.81%
Market Closed Apr 24 15:00 CST
3.86BMarket Cap26.87P/E (TTM)
32.29High31.23Low10.28KlotVolume31.23Open31.43Pre Close32.85MTurnover0.85%Turnover Ratio28.52P/E (Static)120.61MShares48.7552wk High2.87P/B3.86BFloat Cap25.4852wk Low37.72Limit Up120.61MShs Float101.06Historical High25.14Limit Down3.37%Amplitude25.48Historical Low0.55Dividend TTM31.95Avg Price5.04KlotAsk1.72%Div YieldTTM100Lot Size4.76KlotBid
Qingdao Novelbeam Technology Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 24.86%146.89M | -5.90%442.83M | -15.30%318.67M | -17.70%220.42M | -20.74%117.64M | -1.31%470.6M | 10.77%376.25M | 36.48%267.81M | 58.76%148.43M | 53.97%476.82M |
| Operating revenue | 24.86%146.89M | -5.90%442.83M | -15.30%318.67M | -17.70%220.42M | -20.74%117.64M | -1.31%470.6M | 10.77%376.25M | 36.48%267.81M | 58.76%148.43M | 53.97%476.82M |
| Total operating cost | 26.34%90.01M | -7.77%285.45M | -13.39%208.94M | -13.85%140.94M | -21.76%71.24M | 10.93%309.49M | 29.77%241.24M | 50.34%163.6M | 71.18%91.06M | 38.38%279.01M |
| Operating cost | 23.16%51.44M | -7.94%157.17M | -19.17%109.17M | -17.64%79.14M | -20.64%41.77M | 0.43%170.74M | 15.79%135.07M | 43.25%96.1M | 63.28%52.63M | 50.35%170M |
| Operating tax surcharges | 61.32%1.47M | -20.08%5.09M | -34.86%3.54M | -39.85%2.36M | -61.79%913.63K | 45.43%6.37M | 92.87%5.44M | 104.60%3.92M | 289.18%2.39M | 19.83%4.38M |
| Operating expense | 108.77%9.09M | 42.02%25.7M | 19.54%15.65M | 21.46%10.25M | 14.41%4.35M | 16.55%18.1M | 23.50%13.1M | 27.55%8.44M | 45.32%3.8M | 50.22%15.53M |
| Administration expense | 9.44%12.42M | -2.00%52.2M | -0.62%37.79M | -2.79%24.04M | -11.25%11.35M | 25.66%53.26M | 34.59%38.02M | 37.97%24.73M | 55.44%12.79M | 24.58%42.39M |
| Financial expense | 100.23%4.77K | -82.23%-8.87M | 4.73%-4.37M | -39.47%-5.66M | -190.36%-2.08M | 63.11%-4.86M | 64.98%-4.59M | 53.89%-4.06M | 304.71%2.3M | -1,544.81%-13.19M |
| -Interest expense (Financial expense) | --466.92K | 8.31%509.84K | -12.71%282.5K | -78.62%52.5K | ---- | 27.92%470.73K | --323.64K | --245.6K | -50.10%152.69K | 5.20%367.99K |
| -Interest Income (Financial expense) | 7.41%-1.2M | -5.00%-4.86M | -6.94%-3.82M | -10.75%-2.93M | -22.61%-1.3M | 12.42%-4.63M | 6.57%-3.57M | 14.85%-2.65M | 43.19%-1.06M | -32.67%-5.28M |
| Research and development | 4.30%15.59M | -17.83%54.15M | -13.02%47.15M | -10.61%30.81M | -12.82%14.95M | 10.01%65.89M | 33.25%54.21M | 43.17%34.47M | 61.26%17.14M | 44.88%59.9M |
| Credit Impairment Loss | 204.74%524.77K | -219.70%-1.12M | -263.21%-1.06M | -160.67%-401K | 379.14%172.2K | 165.76%937.79K | 158.33%649.09K | 920.06%660.94K | 111.14%35.94K | -224.05%-1.43M |
| Asset Impairment Loss | -1.55%-2.77M | -3.47%-4.77M | -13.59%-3.81M | -0.16%-3.01M | -35.17%-2.73M | -66.55%-4.61M | -45.01%-3.35M | -49.53%-3.01M | -49.74%-2.02M | -18.07%-2.77M |
| Other net revenue | ||||||||||
| Fair value change income | -72.26%327.45K | ---- | -93.87%231.21K | 20.33%1.41M | 313.58%1.18M | --538.64K | 29.85%3.77M | -49.10%1.17M | -87.62%285.45K | ---- |
| Invest income | 6.29%-2.7M | -34.59%-4.95M | 48.53%-3.59M | 18.06%-3.17M | -59.63%-2.89M | -169.27%-3.67M | -260.54%-6.98M | -260.02%-3.87M | -3,832.35%-1.81M | -49.90%5.3M |
| -Including: Investment income associates | 6.29%-2.7M | 3.60%-9.42M | 2.89%-7.5M | 0.12%-4.61M | -44.98%-2.89M | -118.44%-9.77M | -320.66%-7.73M | -547.76%-4.62M | -1,368.57%-1.99M | -14,839.99%-4.47M |
| Asset deal income | ---- | 6,371.91%20.96K | 6,371.91%20.96K | ---- | ---- | -96.07%323.87 | -96.07%323.87 | ---- | ---- | 109.64%8.24K |
| Other revenue | -25.41%1.14M | -4.28%6.38M | 89.15%8.28M | 126.06%5.98M | -24.24%1.53M | -9.77%6.66M | 2.85%4.38M | -22.68%2.65M | 667.08%2.02M | -59.39%7.38M |
| Operating profit | 22.28%53.4M | -4.98%152.94M | -17.73%109.81M | -21.15%80.28M | -21.87%43.67M | -21.98%160.96M | -17.54%133.47M | 8.92%101.81M | 35.51%55.89M | 54.03%206.32M |
| Add:Non operating Income | 991,115.79%3.77K | -21.10%71.37K | 79.23%61.38K | 433.26%43.44K | -99.95%0.38 | -11.44%90.46K | 29.58%34.24K | -4.16%8.15K | --800.06 | 1,279.92%102.15K |
| Less:Non operating expense | 399.80%34.94K | -33.74%538.69K | -10.79%277.08K | -60.63%114.05K | -84.26%6.99K | -12.53%812.97K | -65.83%310.6K | -66.54%289.72K | -68.34%44.41K | 30.67%929.38K |
| Total profit | 22.23%53.37M | -4.84%152.48M | -17.72%109.59M | -21.00%80.21M | -21.82%43.66M | -22.02%160.24M | -17.26%133.2M | 9.63%101.53M | 35.87%55.85M | 54.23%205.49M |
| Less:Income tax cost | 33.25%7.58M | 3.63%18.73M | -24.29%13.17M | -24.64%10.43M | -30.14%5.69M | -24.01%18.07M | -19.57%17.4M | 4.02%13.84M | 48.17%8.14M | 47.88%23.78M |
| Net profit | 20.58%45.79M | -5.92%133.75M | -16.73%96.42M | -20.42%69.78M | -20.40%37.98M | -21.76%142.17M | -16.90%115.79M | 10.57%87.69M | 33.97%47.71M | 55.10%181.71M |
| Net profit from continuing operation | 20.58%45.79M | -5.92%133.75M | -16.73%96.42M | -20.42%69.78M | -20.40%37.98M | -21.76%142.17M | -16.90%115.79M | 10.57%87.69M | 33.97%47.71M | 55.10%181.71M |
| Less:Minority Profit | -92.05%-898.11K | 54.98%-1.6M | 59.31%-977.19K | 53.08%-770.14K | 38.26%-467.64K | -312.60%-3.55M | -353.68%-2.4M | -192.93%-1.64M | -314.09%-757.44K | -50.18%-859.53K |
| Net profit of parent company owners | 21.45%46.69M | -7.11%135.35M | -17.60%97.4M | -21.02%70.55M | -20.68%38.44M | -20.19%145.71M | -15.50%118.2M | 11.85%89.33M | 35.40%48.46M | 55.07%182.57M |
| Earning per share | ||||||||||
| Basic earning per share | 21.88%0.39 | -6.67%1.12 | -16.49%0.81 | -21.62%0.58 | -20.00%0.32 | -20.00%1.2 | -15.65%0.97 | 12.12%0.74 | -2.44%0.4 | 6.38%1.5 |
| Diluted earning per share | 21.88%0.39 | -6.67%1.12 | -16.49%0.81 | -20.55%0.58 | -20.00%0.32 | -20.00%1.2 | -15.65%0.97 | 10.61%0.73 | -2.44%0.4 | 6.38%1.5 |
| Other composite income | -42.22%-439.08K | -21.67%1.73M | -103.26%-73.14K | -100.70%-21.53K | 10.46%-308.73K | 86.79%2.21M | -4.00%2.24M | 229.39%3.08M | 11.77%-344.82K | 241.82%1.18M |
| Other composite income of parent company owners | -42.22%-439.08K | -21.67%1.73M | -103.26%-73.14K | -100.70%-21.53K | 10.46%-308.73K | 86.79%2.21M | -4.00%2.24M | 229.39%3.08M | 11.77%-344.82K | 241.82%1.18M |
| Total composite income | 20.40%45.35M | -6.16%135.48M | -18.38%96.35M | -23.15%69.76M | -20.47%37.67M | -21.06%144.38M | -16.69%118.04M | 13.12%90.77M | 34.48%47.36M | 57.23%182.89M |
| Total composite income of parent company owners | 21.28%46.25M | -7.33%137.08M | -19.19%97.32M | -23.68%70.53M | -20.75%38.13M | -19.50%147.92M | -15.31%120.44M | 14.37%92.41M | 35.93%48.12M | 57.19%183.75M |
| Total composite income of minority owners | -92.05%-898.11K | 54.98%-1.6M | 59.31%-977.19K | 53.08%-770.14K | 38.26%-467.64K | -312.60%-3.55M | -353.68%-2.4M | -192.93%-1.64M | -314.09%-757.44K | -50.18%-859.53K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs